Hong J, Crawford K, Cavanagh E, da Silva Costa F, Kumar S
Mater Research Institute, University of Queensland, South Brisbane, Queensland, Australia.
Faculty of Medicine, The University of Queensland, Herston, Queensland, Australia.
Ultrasound Obstet Gynecol. 2024 May;63(5):635-643. doi: 10.1002/uog.27513.
To assess the association between placental biomarkers (placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1)/PlGF ratio) and fetoplacental Doppler indices (umbilical artery (UA) pulsatility index (PI) and uterine artery (UtA) PI) in various combinations for predicting preterm birth (PTB) in pregnancies complicated by fetal growth restriction (FGR).
This was a prospective observational cohort study, performed at Mater Mother's Hospital in Brisbane, Queensland, Australia, from May 2022 to June 2023, of pregnancies complicated by FGR and appropriate-for-gestational-age (AGA) pregnancies. Maternal serum PlGF levels, sFlt-1/PlGF ratio, UA-PI and UtA-PI were measured at 2-4-weekly intervals from recruitment until delivery. Harrell's concordance statistic (Harrell's C) was used to evaluate multivariable Cox proportional hazards regression models featuring various combinations of placental biomarkers and fetoplacental Doppler indices to ascertain the best combination to predict PTB (< 37 weeks). Multivariable Cox regression models were used with biomarkers as time-varying covariates.
The study cohort included 320 singleton pregnancies, comprising 179 (55.9%) affected by FGR, defined according to a Delphi consensus, and 141 (44.1%) with an AGA fetus. In the FGR cohort, both low PlGF levels and elevated sFlt-1/PlGF ratio were associated with significantly shorter time to PTB. Low PlGF was a better predictor of PTB than was either sFlt-1/PlGF ratio or a combination of PlGF and sFlt-1/PlGF ratio (Harrell's C, 0.81, 0.78 and 0.79, respectively). Although both Doppler indices were significantly associated with time to PTB, in combination they were better predictors of PTB than was either UA-PI > 95 centile or UtA-PI > 95 centile alone (Harrell's C, 0.82, 0.75 and 0.76, respectively). Predictive utility for PTB was best when PlGF < 100 ng/L, UA-PI > 95 centile and UtA-PI > 95 centile were combined (Harrell's C, 0.88) (hazard ratio, 32.99; 95% CI, 10.74-101.32).
Low maternal serum PlGF level (< 100 ng/L) and abnormal fetoplacental Doppler indices (UA-PI > 95 centile and UtA-PI > 95 centile) in combination have the greatest predictive utility for PTB in pregnancies complicated by FGR. Their assessment may help guide clinical management of these complex pregnancies. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
评估胎盘生物标志物(胎盘生长因子(PlGF)和可溶性fms样酪氨酸激酶-1(sFlt-1)/PlGF比值)与胎儿胎盘多普勒指数(脐动脉(UA)搏动指数(PI)和子宫动脉(UtA)PI)的各种组合,用于预测合并胎儿生长受限(FGR)的妊娠中的早产(PTB)。
这是一项前瞻性观察队列研究,于2022年5月至2023年6月在澳大利亚昆士兰州布里斯班的马特母亲医院进行,研究对象为合并FGR的妊娠和适于胎龄(AGA)妊娠。从招募到分娩,每隔2 - 4周测量一次孕妇血清PlGF水平、sFlt-1/PlGF比值、UA-PI和UtA-PI。使用Harrell一致性统计量(Harrell's C)评估多变量Cox比例风险回归模型,该模型包含胎盘生物标志物和胎儿胎盘多普勒指数的各种组合,以确定预测PTB(<37周)的最佳组合。多变量Cox回归模型将生物标志物用作时变协变量。
研究队列包括320例单胎妊娠,其中179例(55.9%)根据德尔菲共识定义为受FGR影响,141例(44.1%)为AGA胎儿。在FGR队列中,低PlGF水平和升高的sFlt-1/PlGF比值均与PTB时间显著缩短相关。低PlGF比sFlt-1/PlGF比值或PlGF与sFlt-1/PlGF比值的组合更能预测PTB(Harrell's C分别为0.81、0.78和0.79)。虽然两个多普勒指数均与PTB时间显著相关,但两者结合比单独的UA-PI>第95百分位数或UtA-PI>第95百分位数更能预测PTB(Harrell's C分别为0.82、0.75和0.76)。当PlGF<100 ng/L、UA-PI>第95百分位数和UtA-PI>第95百分位数相结合时,对PTB的预测效用最佳(Harrell's C为0.88)(风险比为32.99;95%CI为10.74 - 101.32)。
孕妇血清低PlGF水平(<100 ng/L)与异常胎儿胎盘多普勒指数(UA-PI>第95百分位数和UtA-PI>第95百分位数)相结合,对合并FGR的妊娠中的PTB具有最大的预测效用。对它们的评估可能有助于指导这些复杂妊娠的临床管理。© 2023作者。《妇产科超声》由约翰·威利父子有限公司代表国际妇产科超声学会出版。